# FDA Inspection 1300146 - Boehringer Ingelheim Hellas A.E. - June 04, 2024

Source: https://www.keypedia.com/records/fda_inspections/boehringer-ingelheim-hellas-ae/415b1a13-3cc6-4273-8a2a-39e8518105ac
Source feed: FDA_Inspections

> FDA Inspection 1300146 for Boehringer Ingelheim Hellas A.E. on June 04, 2024. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1300146
- Company Name: Boehringer Ingelheim Hellas A.E.
- Inspection Date: 2024-06-04
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1180376 - 2021-05-21](https://www.keypedia.com/records/fda_inspections/boehringer-ingelheim-hellas-ae/af0487aa-9f79-4f84-9d03-687620016ec4)

Company: https://www.keypedia.com/companies/boehringer-ingelheim-hellas-ae/3d05b843-ddcd-47d7-8b0c-de7d170d3197

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c